Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
T
Tarozzo, Maria Martha
School of Pharmaceutical Sciences of Ribeirao Preto - University of Sao Paulo
125
:
Pregabalin-codeine-disease Interactions in Patients With Acute Herpetic or Postherpetic Neuralgia
Maria Martha Tarozzo
Favorite
Taur, Jan-Shiang
US Food & Drug Administration
015
:
Characterizing the Covariates & their Impacts on Statistical Evaluations of Clinical Pharmacology Studies in the 351(k) Biologic License Applications
Jan-Shiang Taur
Favorite
Thalluri, Bhargavi
University of Tennessee health science center
019
:
Clinical Pharmacology Insights into Dosing Strategies of Approved Antibody-Drug Conjugates
Bhargavi Thalluri
Favorite
100
:
Sex-Related Differences in the Pharmacokinetics of Therapeutic Proteins
Bhargavi Thalluri
Favorite
Tian, Xiaofan
Boehringer Ingelheim Pharmaceuticals Inc
062
:
Absolute Oral Bioavailability of Nerandomilast in Healthy Male Study Participants
Xiaofan Tian
Favorite
Tortorici, Michael
Mineralys Therapeutics, Inc.
038
:
Lorundrostat Concentration-QTc Results from the First-in-Human Study in Healthy Participants Demonstrate Lack of Relevant Effect & Replaces the Thorough QT Study
Michael Tortorici
Favorite
Tran, Brittany
Daiichi Sankyo, Inc.
042
:
Pharmacokinetics & Exposure-safety Analyses Across Tumor Types for Ifinatamab Deruxtecan (I-DXd) in the First-in-Human Study IDeate-Pantumor01 (DS7300-A-J101)
Brittany Tran
Favorite
092
:
Concentration-QTc Interim Analysis of I-DXd in Subjects With Advanced Solid Tumors from Study IDeate-Pantumor01 (DS7300-A-J101)
Brittany Tran
Favorite
Tran, Tony
ORISE / US Food & Drug Administration
A002
:
A Comparative Review of Study Population & Dose Recommendations for In Vivo Bioequivalence Studies With Pharmacokinetic Endpoints Between FDA & EMA Guidances
Tony Tran
Favorite
Tseng, Leo
89bio
136
:
Population Pharmacokinetics & Pharmacodynamics of Pegozafermin, a Novel GlycoPEGylated FGF21, in a Phase 2 Study in Severe Hypertriglyceridemia
Leo Tseng
Favorite
